Waheed*1, N., Waheed, S., Al-Dulaimi, A. (2023). فيتامين ج كعامل علاجي ووقائي. , 2(2), 65-75.
Noor Ahmed Waheed*1; Sarah Ahmed Waheed; Amal Al-Dulaimi. "فيتامين ج كعامل علاجي ووقائي". , 2, 2, 2023, 65-75.
Waheed*1, N., Waheed, S., Al-Dulaimi, A. (2023). 'فيتامين ج كعامل علاجي ووقائي', , 2(2), pp. 65-75.
Waheed*1, N., Waheed, S., Al-Dulaimi, A. فيتامين ج كعامل علاجي ووقائي. , 2023; 2(2): 65-75.

فيتامين ج كعامل علاجي ووقائي

مجلة البيان للعلوم الطبية والصحية 
Article 2, Volume 2, Issue 2, December 2023, Pages 65-75    PDF (214.13 K)
Document Type: research paper
Authors
Noor Ahmed Waheed*1* ; Sarah Ahmed Waheed; Amal Al-Dulaimi
Department of Pharmaceutical Chemistry, College of Pharmacy, University of Mosul, Mosul, Iraq
Abstract
يعتبر فيتامين ج عامل مضاد للاكسدة و عامل مساعد للانزيمات المهمة في كثير من المسارات الحيوية مثل تفاعلات الاكسدة والاختزال وتصنيع الكولاجين. داء الاسقربوط الذي تسبب في كثير من الوفيات بين القرنين الخامس عشر والثامن عشر, كان نتيجة نقص في هذا المركب المهم. الجسم البشري غير قادر على تصنيع هذا المركب ولهذا يحتاج الى مصادر خارجية لهذا الفيتامين للحفاظ على صحة القوام النسيجي. حاليا, فيتامين ج يجذب الكثير من الاهتمام لاهميته الحيوية, ولهذا يوجد تزايد في عدد الابحاث التي تدرس علاقته بالامراض وتطورها وعلاجها. في هذه المراجعة, استطلعنا تأثير نقص فيتامين ج وكذلك تناول هذا الفيتامين على مسار مرض السرطان, اصابات الهيكل العظمي و العضلي, العناية بالبشرة, المناعة, الالتهابات, مرض باركنسون, الزيهايمرو الامراض النفسية. استنتجنا ان تناول فيتامين ج قد يزيد من مدة الحياة لمرضى السرطان, يحسن المناعة, يقلل من اعراض الحساسية, يحافظ على سلامة النسيج, يحافظ على سلامة البشرة ويحارب شيخوختها, ويحسن من اعراض الامراض التنكسية العصبية والامراض النفسية.  
Keywords
Vitamin C (VC) is considered a powerful antioxidant and enzyme cofactor that is essential in many biochemical pathways; such as redox reactions and collagen production. Scurvy; a historic disease that caused a large number of deaths among sailors in the 15th and 18th centuries; resulted from a clinical shortage of this essential component. The human body is unable to synthesize this material; so it requires exogenous VC to protect tissue integrity. Nowadays; VC gets a lot of interest due to its importance for various biological activities. An increasing number of articles study the relationship between this vitamin and the incidence of serious diseases; along with the progression and recovery of these diseases. In this review; we explore the effect of deficiency as well as the intake of VC on cancer prognosis; musculoskeletal injuries; skin care; immunity; infections; Parkinson’s; Alzheimer's; and psychiatric diseases. We concluded that VC intake could increase survival time in cancer patients; improve immunity; relieve allergic symptoms; preserve tissue integrity; protect skin from UV harmful effects; fight skin aging; and improve symptoms in neurodegenerative and psychiatric diseases
References
  1. Hemilä H. Vitamin C and infections. Nutrients. 2017;9(4).
  2. Prohan M, Amani R, Nematpour S, Jomehzadeh N, Haghighizadeh MH. Total antioxidant capacity of diet and serum, dietary antioxidant vitamins intake, and serum hs-CRP levels in relation to depression scales in university male students. Redox Rep. 2014;19(3):133–9.
  3. Padayatty SJ, Levine M. Vitamin C: the known and the unknown and Goldilocks. Oral Dis. 2016;22(6):463–93.
  4. Dresen E, Lee ZY, Hill A, Notz Q, Patel JJ, Stoppe C. History of scurvy and use of vitamin C in critical illness: A narrative review. Nutr Clin Pract. 2023;38(1):46–54.
  5. Naidu KA. Vitamin C in human health and disease is still a mystery? An overview. Nutr J. 2003;2:1–10.
  6. Pharm Pharm Sci MJ, Aburawi SM. Vitamin C and human diseases: An overview. J Pharm Pharm Sci [Internet]. 2021;1(4):25–36. Available from: www.medjpps.com
  7. Ward MS, Lamb J, May JM, Harrison FE. Behavioral and monoamine changes following severe vitamin C deficiency. J Neurochem. 2013;124(3):363–75.
  8. Mousavi S, Bereswill S, Heimesaat MM. Immunomodulatory and antimicrobial effects of vitamin C. Eur J Microbiol Immunol. 2019;9(3):73–9.
  9. Mohammed BM, Fisher BJ, Kraskauskas D, Ward S, Wayne JS, Brophy DF, et al. Vitamin C promotes wound healing through novel pleiotropic mechanisms. Int Wound J. 2016;13(4):572–84.
  10. Lopresti AL. A review of nutrient treatments for paediatric depression. J Affect Disord [Internet]. 2015;181:24–32. Available from: http://dx.doi.org/10.1016/j.jad.2015.04.014
  11. Telang P. Vitamin C in dermatology. Indian Dermatol Online J. 2013;4(2):143.
  12. Kocot J, Luchowska-Kocot D, Kiełczykowska M, Musik I, Kurzepa J. Does vitamin c influence neurodegenerative diseases and psychiatric disorders? Nutrients. 2017;9(7).
  13. Sawicka-Glazer E, Czuczwar SJ. Vitamin C: A new auxiliary treatment of epilepsy? Pharmacol Reports [Internet]. 2014;66(4):529–33. Available from: http://dx.doi.org/10.1016/j.pharep.2014.02.016
  14. Wintergerst ES, Maggini S, Hornig DH. Immune-enhancing role of Vitamin C and zinc and effect on clinical conditions. Ann Nutr Metab. 2006;50(2):85–94.
  15. Rosa PB, Neis VB, Ribeiro CM, Moretti M, Rodrigues ALS. Antidepressant-like effects of ascorbic acid and ketamine involve modulation of GABAA and GABAB receptors. Pharmacol Reports [Internet]. 2016;68(5):996–1001. Available from: http://dx.doi.org/10.1016/j.pharep.2016.05.010
  16. Wang Y, Liu XJ, Robitaille L, Eintracht S, MacNamara E, John Hoffer L. Effects of vitamin C and vitamin D administration on mood and distress in acutely hospitalized patients. Am J Clin Nutr. 2013;98(3):705–11.
  17. Bos GMJ. nutrients The E ff ect of Vitamin C ( Ascorbic Acid ) in the Treatment of Patients with Cancer : A Systematic Review. 2019;
  18. Hacişevki A. An overview of ascorbic acid biochemistry. Ankara Univ Eczac Fak Derg. 2009;38(3):233–55.
  19. Yin X, Chen K, Cheng H, Chen X, Feng S, Song Y, et al. Chemical Stability of Ascorbic Acid Integrated into Commercial Products: A Review on Bioactivity and Delivery Technology. Antioxidants. 2022;11(1):1–20.
  20. Tu YJ, Njus D, Schlegel HB. A theoretical study of ascorbic acid oxidation and HOO / O 2- Radical scavenging. Org Biomol Chem. 2017;15(20):4417–31.
  21. Information NC for B. n.d. 2023. No Title. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Ascorbic-Acid
  22. Croce CM. Oncogenes and cancer. supplementary appendix. N Engl J Med [Internet]. 2008;358(5):503-. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18234754
  23. Pettini F, Visibelli A, Cicaloni V, Iovinelli D, Spiga O. Multi-omics model applied to cancer genetics. Int J Mol Sci. 2021;22(11):1–21.
  24. Tellez-Gabriel M, Ory B, Lamoureux F, Heymann MF, Heymann D. Tumour heterogeneity: The key advantages of single-cell analysis. Int J Mol Sci. 2016;17(12).
  25. Cameron E, Campbell A. The orthomolecular treatment of cancer II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer. Chem Biol Interact. 1974;9(4):285–315.
  26. Creagan E, Moertel C, O’Fallon J, Schutt A, O’Connell M, Rubin J, et al. Failure of High-Dose Vitamin C Therapy to Benefit Patient with Advanced Cancer. N Engl J Med . 1979;301:687–90.
  27. Hickey S, Roberts HJ, Miller NJ. Pharmacokinetics of oral vitamin C. J Nutr Environ Med. 2008;17(3):169–77.
  28. Levine M, Padayatty SJ, Espey MG. Vitamin C: A concentration-function approach yields pharmacology and therapeutic discoveries. Adv Nutr. 2011;2(2):78–88.
  29. Fritz H, Flower G, Weeks L, Cooley K, Callachan M, McGowan J, et al. Intravenous vitamin C and cancer: A systematic review. Integr Cancer Ther. 2014;13(4):280–300.
  30. Jacobs C, Hutton B, Ng T, Shorr R, Clemons M. Is There a Role for Oral or Intravenous Ascorbate (Vitamin C) in Treating Patients With Cancer? A Systematic Review. Oncologist. 2015;20(2):210–23.
  31. Nauman G, Gray JC, Parkinson R, Levine M, Paller CJ. Systematic review of intravenous ascorbate in cancer clinical trials. Antioxidants. 2018;7(7):1–22.
  32. Ma Y, Chapman J, Levine M, Polireddy K, Drisko J, Chen Q. Cancer: High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy. Sci Transl Med. 2014;6(222).
  33. AJ Thanoon I, R Jadoa K, A Ahmed F. Oxidant/antioxidant status in serum of breast cancer women treated by surgical interference and chemotherapy. Iraqi J Pharm. 2013;13(1):7–12.
  34. Woo A, Kim JH, Jeong YJ, Maeng HG, Lee YT, Kang JS, et al. Vitamin C acts indirectly to modulate isotype switching in mouse B cells. Anat Cell Biol. 2010;43(1):25.
  35. Ströhle A, Wolters M, Hahn A. Micronutrients at the interface between inflammation and infection - ascorbic acid and calciferol. part 1: General overview with a focus on ascorbic acid. Inflamm Allergy - Drug Targets. 2011;10(1):54–63.
  36. Mumtaz S, Mumtaz S, Ali S, Tahir HM, Kazmi SAR, Mughal TA, et al. Evaluation of antibacterial activity of vitamin C against human bacterial pathogens. Brazilian J Biol. 2023;83:1–8.
  37. Golonka I, Oleksy M, Junka A, Matera-witkiewicz A, Bartoszewicz M, Musiał W. Selected Physicochemical and Biological Properties of Ethyl Ascorbic Acid Compared to Ascorbic Acid. 2017;40(8):1199–206.
  38. Mirani ZA, Khan MN, Siddiqui A, Khan F, Naz S, Ahmed A, et al. Ascorbic acid augments colony spreading by reducing biofilm formation of methicillin-resistant Staphylococcus aureus. 2017;(7).
  39. van Asbeck BS, Marcelis JH, Marx JJM, Struyvenberg A, van Kats JH, Verhoef J. Inhibition of bacterial multiplication by the iron chelator deferoxamine: Potentiating effect of ascorbic acid. Eur J Clin Microbiol. 1983;2(5):426–31.
  40. Zojaji H, Talaie R, Mirsattari D, Haghazali M, Molaei M, Mohsenian N, et al. The efficacy of Helicobacter pylori eradication regimen with and without vitamin C supplementation. Dig Liver Dis. 2009;41(9):644–7.
  41. Kumari P, Dembra S, Dembra P, Bhawna F, Gul A, Ali B, et al. The Role of Vitamin C as Adjuvant Therapy in COVID-19. Cureus. 2020;12(11):10–3.
  42. Colunga Biancatelli RML, Berrill M, Marik PE. The antiviral properties of vitamin C. Expert Rev Anti Infect Ther [Internet]. 2020;18(2):99–101. Available from: https://doi.org/10.1080/14787210.2020.1706483
  43. Vollbracht C, Raithel M, Krick B, Kraft K, Hagel AF. Intravenous vitamin C in the treatment of allergies: an interim subgroup analysis of a long-term observational study. J Int Med Res. 2018;46(9):3640–55.
  44. Sharma SR, Poddar R, Sen P, Andrews JT. Effect of vitamin C on collagen biosynthesis and degree of birefringence in polarization sensitive optical coherence tomography (PS-OCT). African J Biotechnol. 2008;7(12):2049–54.
  45. Manela-Azulay M, Bagatin E. Cosmeceuticals vitamins. Clin Dermatol [Internet]. 2009;27(5):469–74. Available from: http://dx.doi.org/10.1016/j.clindermatol.2009.05.010
  46. Shaikh H, Faisal MS, Mewawalla P. Vitamin C deficiency: rare cause of severe anemia with hemolysis. Int J Hematol [Internet]. 2019;109(5):618–21. Available from: http://dx.doi.org/10.1007/s12185-018-02575-w
  47. Ömeroǧlu S, Peker T, Türközkan N, Ömeroǧlu H. High-dose vitamin C supplementation accelerates the Achilles tendon healing in healthy rats. Arch Orthop Trauma Surg. 2009;129(2):281–6.
  48. Hung L kim, Fu S chuen, Lee Y wa, Mok T yu, Chan K ming. Local Vitamin-C Injection Reduced Tendon. 2013;41:1–7.
  49. Sarisözen B, Durak K, Dinçer G, Bilgen OF. The effects of vitamins E and C on fracture healing in rats. J Int Med Res. 2002;30(3):309–13.
  50. Duygulu F, Yakan B, Karaoglu S, Kutlubay R, Karahan OI, Ozturk A. The effect of zymosan and the protective effect of various antioxidants on fracture healing in rats. Arch Orthop Trauma Surg. 2007;127(7):493–501.
  51. Yilmaz C, Erdemli E, Selek H, Kinik H, Arikan M, Erdemli B. The contribution of vitamin C to healing of experimental fractures. Arch Orthop Trauma Surg. 2001;121(7):426–8.
  52. Yi N, Chiang Z. Topical Vitamin C and the Skin. Jcad J Clin Aesthetic Dermatology. 2017;14(7):14–7.
  53. Ando H, Kondoh H, Ichihashi M, Hearing VJ. Approaches to identify inhibitors of melanin biosynthesis via the quality control of tyrosinase. J Invest Dermatol. 2007;127(4):751–61.
  54. Hwang SW, Oh DJ, Lee D, Kim JW, Park SW. Clinical efficacy of 25% L-Ascorbic acid (C’ensil) in the treatment of melasma. J Cutan Med Surg. 2009;13(2):74–81.
  55. Luscher B, Shen Q, Sahir N. The GABAergic deficit hypothesis of major depressive disorder. Mol Psychiatry. 2011;16(4):383–406.
  56. Moretti M, Budni J, Ribeiro CM, Rieger DK, Leal RB, Rodrigues ALS. Subchronic administration of ascorbic acid elicits antidepressant-like effect and modulates cell survival signaling pathways in mice. J Nutr Biochem [Internet]. 2016;38:50–6. Available from: http://dx.doi.org/10.1016/j.jnutbio.2016.09.004
  57. Acuña AI, Esparza M, Kramm C, Beltrán FA, Parra A V., Cepeda C, et al. A failure in energy metabolism and antioxidant uptake precede symptoms of Huntington’s disease in mice. Nat Commun. 2013;4(May):1–13.
  58. Moretti M, Budni J, Ribeiro CM, Rodrigues ALS. Involvement of different types of potassium channels in the antidepressant-like effect of ascorbic acid in the mouse tail suspension test. Eur J Pharmacol [Internet]. 2012;687(1–3):21–7. Available from: http://dx.doi.org/10.1016/j.ejphar.2012.04.041
  59. Gautam M, Agrawal M, Gautam M, Sharma P, Gautam A, Gautam S. Role of antioxidants in generalised anxiety disorder and depression. Indian J Psychiatry. 2012;54(3):244–7.
  60. Bajpai A, Verma AK, Srivastava M, Srivastava R. Oxidative stress and major depression. J Clin Diagnostic Res. 2014;8(12):CC04–7.
  61. Rubio-López N, Morales-Suárez-Varela M, Pico Y, Livianos-Aldana L, Llopis-González A. Nutrient intake and depression symptoms in Spanish children: The ANIVA study. Int J Environ Res Public Health. 2016;13(3).
  62. Kim TH, Choi J young, Lee HH, Park Y. Associations between Dietary Pattern and Depression in Korean Adolescent Girls. J Pediatr Adolesc Gynecol [Internet]. 2015;28(6):533–7. Available from: http://dx.doi.org/10.1016/j.jpag.2015.04.005
  63. Amr M, El-mogy A, Shams T, Vieira K, Lakhan SE. Vita C Trial MDD Children. Nutr J. 2013;12(31):1–8.
  64. Zhang M, Robitaille L, Eintracht S, Hoffer LJ. Vitamin C provision improves mood in acutely hospitalized patients. Nutrition [Internet]. 2011;27(5):530–3. Available from: http://dx.doi.org/10.1016/j.nut.2010.05.016
  65. Khajehnasiri, F.; Akhondzadeh, S.; Mortazavi, S.B.; Allameh, A.; Sotoudeh, G.; Khavanin, A.; Zamanian Z. Are Supplementation of Omega-3 and Ascorbic Acid Effective in Reducing Oxidative Stress and Depression among Depressed Shift Workers? Int J Vitam Nutr Res. 2016;10(5):299–310.
  66. Arroll MA, Wilder L, Neil J. Nutritional interventions for the adjunctive treatment of schizophrenia: A brief review. Nutr J. 2014;13(1):1–9.
  67. Firth J, Carney R, Stubbs B, Teasdale SB, Vancampfort D, Ward PB, et al. Nutritional deficiencies and clinical correlates in first-episode psychosis: A systematic review and meta-analysis. Schizophr Bull. 2018;44(6):1275–92.
  68. Bentsen H, Osnes K, Refsum H, Solberg DK, Bøhmer T. A randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E+C in schizophrenia. Transl Psychiatry. 2013;3(October).
  69. Sivrioglu EY, Kirli S, Sipahioglu D, Gursoy B, Sarandöl E. The impact of ω-3 fatty acids, vitamins E and C supplementation on treatment outcome and side effects in schizophrenia patients treated with haloperidol: An open-label pilot study. Prog Neuro-Psychopharmacology Biol Psychiatry. 2007;31(7):1493–9.
  70. A.K. hamid N. The effect of antioxidant supplementation in the treatment of epilepsy. Iraqi J Pharm. 2011;11(2):27–33.
  71. Su B, Liu H, Wang X, Chen SG, Siedlak SL, Kondo E, et al. Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson’s disease. Mol Neurodegener. 2009;4(1):1–5.
  72. He XB, Kim M, Kim SY, Yi SH, Rhee YH, Kim T, et al. Vitamin C facilitates dopamine neuron differentiation in fetal midbrain through TET1- and JMJD3-dependent epigenetic control manner. Stem Cells. 2015;33(4):1320–32.
  73. Ballaz S, Morales I, Rodríguez M, Obeso JA. Ascorbate prevents cell death from prolonged exposure to glutamate in an in vitro model of human dopaminergic neurons. J Neurosci Res. 2013;91(12):1609–17.
  74. Quiroga MJ, Carroll DW, Brown TM. Ascorbate- and Zinc-Responsive Parkinsonism. Ann Pharmacother. 2014;48(11):1515–20.
  75. Ide K, Yamada H, Umegaki K, Mizuno K, Kawakami N, Hagiwara Y, et al. Lymphocyte vitamin C levels as potential biomarker for progression of Parkinson’s disease. Nutrition [Internet]. 2015;31(2):406–8. Available from: http://dx.doi.org/10.1016/j.nut.2014.08.001
  76. Nagayama H, Hamamoto M, Ueda M, Nito C, Yamaguchi H, Katayama Y. The effect of ascorbic acid on the pharmacokinetics of levodopa in elderly patients with Parkinson disease. Clin Neuropharmacol. 2004;27(6):270–3.
  77. Mariam I, Ali S, Rehman A, Ikram‑ul‑Haq. L-Ascorbate, a strong inducer of L-dopa (3,4-dihydroxy-L-phenylalanine) production from pre-grown mycelia of Aspergillus oryzae NRRL-1560 . Biotechnol Appl Biochem. 2010;55(3):131–7.
  78. Warner TA, Kang JQ, Kennard JA, Harrison FE. Low brain ascorbic acid increases susceptibility to seizures in mouse models of decreased brain ascorbic acid transport and Alzheimer’s disease. Epilepsy Res [Internet]. 2015;110:20–5. Available from: http://dx.doi.org/10.1016/j.eplepsyres.2014.11.017
  79. Dixit S, Bernardo A, Walker JM, Kennard JA, Kim GY, Kessler ES, et al. Vitamin C Deficiency in the Brain Impairs Cognition, Increases Amyloid Accumulation and Deposition, and Oxidative Stress in APP/PSEN1 and Normally Aging Mice. ACS Chem Neurosci. 2015;6(4):570–81.
  80. Murakami K, Murata N, Ozawa Y, Kinoshita N, Irie K, Shirasawa T, et al. Vitamin C restores behavioral deficits and amyloid-β oligomerization without affecting plaque formation in a mouse model of alzheimer’s disease. J Alzheimer’s Dis. 2011;26(1):7–18.
  81. Lam V, Hackett M, Takechi R. Antioxidants and dementia risk: Consideration through a cerebrovascular perspective. Nutrients. 2016;8(12):1–18.
  82. Arlt S, Müller-Thomsen T, Beisiegel U, Kontush A. Effect of one-year vitamin C-and E-supplementation on cerebrospinal fluid oxidation parameters and clinical course in alzheimer’s disease. Neurochem Res. 2012;37(12):2706–14.
  83. Galasko DR, Peskind E, Clark CM, Quinn JF, Ringman JM, Jicha GA, et al. Antioxidants for Alzheimer disease: A randomized clinical trial with cerebrospinal fluid biomarker measures. Arch Neurol. 2012;69(7):836–41.
  84. Li Y, Liu S, Man Y, Li N, Zhou Y. Effects of vitamins E and C combined with β carotene on cognitive function in the elderly. Exp Ther Med. 2015;9(4):1489–93.
  85. Zandi PP, Anthony JC, Khachaturian AS, Stone S V., Gustafson D, Tschanz JAT, et al. Reduced Risk of Alzheimer Disease in Users of Antioxidant Vitamin Supplements: The Cache County Study. Arch Neurol. 2004;61(1):82–8.
  86. Ferraro PM, Curhan GC, Gambaro G, Taylor EN. Total, dietary, and supplemental Vitamin C intake and risk of incident kidney stones. Am J Kidney Dis [Internet]. 2016;67(3):400–7. Available from: http://dx.doi.org/10.1053/j.ajkd.2015.09.005
 

Statistics
Article View: 3,883
PDF Download: 175


Journal Management System. Powered by iJournalPro.com